| Absorption |
| Blood-Brain Barrier | BBB- | 0.9294 |
| Human Intestinal Absorption | HIA+ | 0.9870 |
| Caco-2 Permeability | Caco2- | 0.8957 |
| P-glycoprotein Substrate | Substrate | 0.7292 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9064 |
| Non-inhibitor | 0.9460 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7992 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4240 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7004 |
| CYP450 2D6 Substrate | Non-substrate | 0.7055 |
| CYP450 3A4 Substrate | Non-substrate | 0.6250 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9045 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.8932 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9026 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8308 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8681 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8130 |
| Non-inhibitor | 0.7963 |
| AMES Toxicity | Non AMES toxic | 0.8609 |
| Carcinogens | Non-carcinogens | 0.9011 |
| Fish Toxicity | High FHMT | 0.9382 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.7943 |
| Honey Bee Toxicity | Low HBT | 0.5766 |
| Biodegradation | Not ready biodegradable | 0.9174 |
| Acute Oral Toxicity | III | 0.7375 |
| Carcinogenicity (Three-class) | Non-required | 0.6870 |